(Q86999417)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Testosterone and insulin resistance in the metabolic syndrome and T2DM in men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

1 reference

1 reference

1 reference

Preethi M Rao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Daniel M Kelly

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

T Hugh Jones

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

25 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

number of pages

15

1 reference

Nature Reviews Endocrinology

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

479-493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.122

3 March 2020

exact match

0 references

cites work

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone deficiency: a risk factor for cardiovascular disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone: a vascular hormone in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Waist circumference and testosterone levels in community dwelling men. The Tromsø study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Contribution of age and declining androgen levels to features of the metabolic syndrome in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Is Hypoandrogenemia a Component of Metabolic Syndrome in Males?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Type 2 diabetes mellitus and testosterone: a meta-analysis study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Insulin resistance and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone and regional fat distribution.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Insulin resistance and its treatment by thiazolidinediones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Mechanisms of insulin resistance in humans and possible links with inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

13C/31P NMR studies on the mechanism of insulin resistance in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Lipotoxic diseases of nonadipose tissues in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Inflammatory pathways and insulin action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Cytokines and hypothalamic-pituitary function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

The role of leptin in human obesity and disease: a review of current evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Multimodal Influence of Estrogen upon Gonadotropin-Releasing Hormone Neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Regulation of the neuroendocrine reproductive axis by kisspeptin-GPR54 signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Decreased expression of kisspeptin mediates acute immune/inflammatory stress-induced suppression of gonadotropin secretion in female rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt--a major factor in the genesis of morbid obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Endogenous testosterone and serum lipids in middle-aged men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effects of testosterone on sexual function in men: results of a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Treatment of 161 Men with Symptomatic Late Onset Hypogonadism with Long-Acting Parenteral Testosterone Undecanoate: Effects on Body Composition, Lipids, and Psychosexual Complaints

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence. Correlation with plasma testosterone levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Lipoprotein-lipase action determining plasma high density lipoprotein cholesterol level in adult normolipaemics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men. A placebo controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone decreases lipoprotein(a) in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone and atherosclerosis in aging men: purported association and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Cardiovascular aspects of sexual medicine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Erectile dysfunction and mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Low serum testosterone and mortality in male veterans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Low serum testosterone and increased mortality in men with coronary heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone and metabolic syndrome: a meta-analysis study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Low testosterone in men with type 2 diabetes: significance and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Sex hormones and sexual function in obese men losing weight

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone: a metabolic hormone in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Fat in liver/muscle correlates more strongly with insulin sensitivity in rats than abdominal fat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Regulated transport of the glucose transporter GLUT4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Signaling pathways in insulin action: molecular targets of insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Sex steroids deficiency impairs glucose transporter 4 expression and its translocation through defective Akt phosphorylation in target tissues of adult male rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Androgens increase insulin receptor mRNA levels, insulin binding, and insulin responsiveness in HEp-2 larynx carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Sex steroids enhance insulin receptors and glucose oxidation in Chang liver cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Sex steroids influence glucose oxidation through modulation of insulin receptor expression and IRS-1 serine phosphorylation in target tissues of adult male rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone or 17{beta}-estradiol exposure reveals sex-specific effects on glucose and lipid metabolism in human myotubes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

The effect of testosterone on glycogen metabolism in rat levator ani muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

The effect of castration and testosterone propionate injection on glycogen storage in skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Androgen-estrogen synergy in rat levator ani muscle: glucose-6-phosphate dehydrogenase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Voluntary running, skeletal muscle gene expression, and signaling inversely regulated by orchidectomy and testosterone replacement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone plus low-intensity physical training in late life improves functional performance, skeletal muscle mitochondrial biogenesis, and mitochondrial quality control in male mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Modulation of fatty-acid-binding protein content of rat heart and skeletal muscle by endurance training and testosterone treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone acts as a coronary vasodilator by a calcium antagonistic action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone treatment for men with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone supplementation improves spatial and verbal memory in healthy older men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone influences spatial cognition in older men.

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

31 March 2020

12 December 2020

The role of aromatization in testosterone supplementation: effects on cognition in older men.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Is testosterone treatment good for the prostate? Study of safety during long-term treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.122

Relationship of sex hormones to lipids and lipoproteins in nondiabetic men

31 March 2020

1 reference

12 December 2020

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

12 December 2020

Androgen deficiency and mitochondrial dysfunction: implications for fatigue, muscle dysfunction, insulin resistance, diabetes, and cardiovascular disease

1 reference

12 December 2020

[THE EFFECT OF TESTOSTERONE PROPIONATE ON GLYCOLYTIC AND TRANSAMINATION ENZYME ACTIVITIES IN THE LIVER, BICEPS MUSCLE AND LEVATOR ANI MUSCLE IN RATS.]

1 reference

12 December 2020

Differential response of rat skeletal muscle glycogen metabolism to testosterone and estradiol

1 reference

12 December 2020

High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment

1 reference

12 December 2020

[Effects of testosterone on insulin receptor substrate-1 and glucose transporter 4 expression in cells sensitive to insulin]

1 reference

12 December 2020

Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes.

1 reference

12 December 2020

Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels

1 reference

12 December 2020

Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study

1 reference

12 December 2020

Relationship of insulin secretory pulses to sex hormone-binding globulin in normal men.

1 reference

12 December 2020

Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study.

1 reference

12 December 2020

A critical evaluation of simple methods for the estimation of free testosterone in serum.

1 reference

12 December 2020

Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men

1 reference

12 December 2020

Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency

1 reference

12 December 2020

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

1 reference

12 December 2020

Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.

1 reference

12 December 2020

Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients

1 reference

12 December 2020

Testosterone supplementation for erectile dysfunction: results of a meta-analysis

1 reference

12 December 2020

Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate

1 reference

12 December 2020

Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens

1 reference

12 December 2020

Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study.

1 reference

12 December 2020

The effects of testosterone treatment on body composition and metabolism in middle-aged obese men

1 reference

12 December 2020

Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23797822%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference